Collaborators

NOVEMBER 2022

EpiAxis enters agreement with Seattle Children’s Research Institute

SEPTEMBER 2022

EpiAxis enters strategic partnership with UHN

AUGUST 2022

EpiAxis & Peptilogics enter strategic drug discovery partnership

DECEMBER 2021

EpiAxis expands its PKC theta pre-clinical program with Mount Sinai